Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (Stock Code: 06990) has released its Monthly Return on Movements in Securities for the period ended October 31, 2025. According to the return, the total authorized/registered share capital amounted to RMB 233,185,969, with no change observed during the month. The company’s capital structure comprises three classes of ordinary shares: H shares listed on the Stock Exchange (162,769,979 shares), domestic shares (65,773,800 shares), and unlisted foreign shares (4,642,190 shares), all of which remained unchanged from the preceding month.

The issued shares for each category have also experienced no movement during the reporting period. The H shares remain at 162,769,979, with domestic shares at 65,773,800 and unlisted foreign shares at 4,642,190. The monthly return states that no new share options, warrants, or convertibles were issued, and there were no treasury shares or share repurchases. The company confirms compliance with applicable listing rules and related regulatory requirements for the period under review.